Zebrafish Model Prevents Unnecessary SMA Treatment After False-Positive Newborn Screening
Research from Germany and Australia shows zebrafish functional testing can identify false-positive SMA newborn screening results, preventing unnecessary treatment in rare cases where infants carry functional SMN1 gene variants.